CrownBio is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research.Founded in 2006, CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today’s most advanced drug development challenges.Our portfolio translational platforms provide insight and understanding about a drug’s efficacy, pharmacological profile, and patient response profile. This reduce failure in the clinic and supports the selection of the right patients for the right therapy.CrownBio’s fast-paced R&D programs are yielding novel, yet well-validated models at the cutting-edge of disease research.In 2018, JSR Corporation acquired Crown Bioscience to be a strategic part of its global JSR Life Sciences division.